Penboy:


The initial prices were derived after reverse stock spilts o.
Didn't mean it traded at the 15K price.

But yes, holders are in deep shit already.

Lexusgs430:
[/b]


This is the koko..... 😁🤣

Penboy:


The initial prices were derived after reverse stock spilts o.
Didn't mean it traded at the 15K price.

But yes, holders are in deep shit already.

Penboy:
$JAGX prepping for a reverse stock spilt?!
Omo!

aremso:


But it has delivered more than 200% before now if am in it as I bagged my 150-200% I don Japa be that ooo

Aremsssoo:
Foxo!

aremso:
K.TRA...

Penboy:


This stock no serious o.
And I no want play the rinse and repeat strategy

Penboy:
Aremso, checkout $SPCB

Aremsssoo:
Foxo!

aremso:


Was gaining 7% before it closed at -1.99% needs to brake that wall of 0.45, those guys needs to do a fantastic PR then the wall will crumble.

Zagee:

Earning reports should have been giving us something to play with. Don't know why the delay in the Q4 report.

aremso:


Is ok, on my watch list since but not on bamboo

Penboy:


You use Bamboo?

aremso:
KTRA...... 100% delivered

Foxo don't sleep oooo

Penboy:
Stock Symbol: KTRA

Current Price: $0.272 USD1

Market Cap: $10.39 million USD

52-Week Range: $0.081 - $5.60

Sector: Biotechnology / Healthcare

Overview: Kintara Therapeutics is a clinical-stage drug development company focused on developing and commercializing anti-cancer therapies.

They have two late-stage, Phase III-ready therapeutics:

VAL-083: A DNA-targeting agent for the treatment of drug-resistant solid tumors, including glioblastoma multiforme, ovarian cancer, non-small cell lung cancer, and diffuse intrinsic pontine glioma.

REM-001: A late-stage photodynamic therapy for cutaneous metastatic breast cancer, basal cell carcinoma nevus syndrome, and access graft failure in hemodialysis patients.


Merger Agreement: Kintara has entered into a definitive merger agreement with TuHURA Biosciences1. This all-stock transaction is expected to close in the third quarter of 2024.

Clinical Trials: The company announced the expansion of the REM-001 clinical study to include patients on Pembrolizumab (KEYTRUDA®) for cutaneous metastatic breast cancer (CMBC)1. Additionally, a single Phase 3 trial for IFx-2.0 personalized cancer vaccine as adjunctive therapy with Keytruda® in first-line therapy for advanced Merkel cell carcinoma is planned for the second half of 2024 under FDA’s accelerate.

Penboy:


Are you taking profit yet?!

aremso:
From the research I did, most people trading pennies usually blow up their accounts in the 1-2yrs of their trading. I thank God I didn't but learnt some hard lessons thereby giving my huge profits back to the market. I also research that is a market where small money can turn to big money but u must be smart and know what you are doing and this i confirmed from my friends account under my watch from 192 now going to 1k in KTRA which I will do the needful so affliction doesn't rise the second time. The market is not for the faint hearted as this is not naija stock market but the rewards can be enormous if one knows what is doing. My friend bought HLTH then according to what I said and me that gave it have booked my looses and moved but my friend still holding pennies like warren Buffett stocks now over 400 losses is that not madness and even when the stock went up abit and had opportunity to exit was still holding and he had made 900 on my o T R K call instead of him to let go when the losses never gotten to that level he, holding like the way is holding crypto. NSE has made some of us something else.
I know one day, one week , one month and one yr I don't know how long it will be I will hit 100k 200k 500k 800k and $ 1m in this market by God grace. Is a place to be.